Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-10 @ 3:13 PM
Study NCT ID:
NCT03053856
Status:
UNKNOWN
Last Update Posted:
2017-02-15
First Post:
2017-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-14
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-05-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-08-13
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-06
First Submit QC Date:
None
Study First Post Date:
2017-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-14
Last Update Post Date:
2017-02-15
Last Update Post Date Type:
ACTUAL